Applied Therapeutics logo
Applied Therapeutics APLT

Quarterly report 2025-Q3
added 11-13-2025

report update icon

Applied Therapeutics Market Cap 2011-2026 | APLT

As of May 01, 2026 Applied Therapeutics has a market cap of $ 8.42 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Applied Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
541 M 35.2 M 78.8 M 470 M 682 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
682 M 35.2 M 361 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
315 M - 2.43 % $ 254 M germanyGermany
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
8.59 B $ 9.85 2.66 % $ 637 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
14.1 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
127 M - - $ 866 M chinaChina
Akero Therapeutics Akero Therapeutics
AKRO
3.25 B - - $ 3.67 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
2.09 B $ 5.12 3.75 % $ 820 M britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
79 M - -18.52 % $ 27.3 M britainBritain
AlloVir AlloVir
ALVR
13.1 M - 4.14 % $ 49.1 M usaUSA
BioNTech SE BioNTech SE
BNTX
62.9 B $ 98.05 -5.22 % $ 27.2 B germanyGermany
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
33.6 B - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
549 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
168 B - 2.54 % $ 160 B franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
3.19 B $ 21.95 -2.23 % $ 3.64 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
1.62 M - - $ 269 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
22.1 M - - $ 10.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.72 M - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
81.2 B - - $ 96.9 B britainBritain
Cerus Corporation Cerus Corporation
CERS
496 M $ 2.57 26.59 % $ 490 M usaUSA
Atreca Atreca
BCEL
49 M - -11.76 % $ 5.79 M usaUSA
Berkeley Lights Berkeley Lights
BLI
117 M - -7.31 % $ 87 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
960 M - -10.95 % $ 876 K usaUSA
Advaxis Advaxis
ADXS
1.87 M - -9.65 % $ 45.9 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
3.43 B - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
1.82 M - - $ 3.74 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.83 B - - - russiaRussia
Caladrius Biosciences Caladrius Biosciences
CLBS
3.58 M - -16.75 % $ 25.8 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
52.7 M - - $ 231 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
116 M $ 1.72 -0.87 % $ 115 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
41.4 M - 5.93 % $ 314 M canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
6.33 M - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
724 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
32.8 M - - $ 26.5 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
1.2 B - - $ 2.18 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
19.6 M - 1.93 % $ 17.4 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
1.73 B - - $ 2.02 B usaUSA
Akouos Akouos
AKUS
172 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
114 M - - $ 28.6 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
4.81 M $ 2.91 -8.78 % $ 4.79 M israelIsrael
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
3.11 M - -9.21 % $ 2.55 M usaUSA
Editas Medicine Editas Medicine
EDIT
206 M $ 2.9 -3.27 % $ 257 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
6.08 M $ 18.92 3.53 % $ 60.5 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
6.15 M - -5.68 % $ 8.28 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.53 B - - $ 867 M germanyGermany
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
664 K - -11.43 % $ 502 K usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.32 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
9.48 M - -39.0 % $ 4.57 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
66.3 M $ 0.78 - $ 27.9 M israelIsrael
Aravive Aravive
ARAV
60.4 M - -13.39 % $ 1.45 M usaUSA